Dynamics and mechanism of sodium-dependent carboxylate transporters

Active Project Grant Awarded Last action

Award ID
R01DK135088
Recipient
Awarding agency
Obligated
$7,664,997

Award facts

Completion date 98% complete
Place of performance
New York, NY 10016, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
The plasma membrane-bound sodium-dependent citrate transporter (NACT) plays a major role in fatty acid biosynthesis and thus represents a major therapeutic target for various metabolic diseases. Its bacterial homolog, vcindy, is a prototype of the entire divalent anion sodium symporter (DASS) family, of which NACT is also a member. Despite the enormous progress that has been made, major gaps remain in our current understanding of the molecular mechanisms of NACT, vcindy, and other secondary membrane transporters. In particular, we do not know how a transporter works in real-time. At best, mechanistic descriptions of the transport cycles of these transporters consist of a series of structural snapshots of some of the individual states, along with limited kinetic parameters connecting the various states obtained from ensemble measurements. In this project, we aim to characterize the structure, dynamics, function, and inhibition of these two sodium-driven carboxylate transporters. (1) we will first characterize the structural basis of sodium-substrate coupling in vcindy and NACT. We will identify the ION stoichiometry and the positions and structures of the unknown sodium sites in the transporters. Following measurements of sodium-dependent substrate binding in solution, we will determine the structures of the transporters in the presence and absence of sodium using cryo-EM. Any hypothesis suggested by such structures will be examined by biochemical experiments. (2) using smfret, we will characterize the real-time dynamics with which vcindy and NACT transition between the outward- and inward-facing states during transport. Specifically, we will identify the number of conformational states that are sampled during transport and determine the rates of transitions between those states. Using this framework, we will investigate how the sodium ions and substrates that generate the driving force for transport modulate these parameters. These experimental measurements will be integrated into computational models generated by MD simulations. (3) we will aim to understand the entire reaction cycle of the transporter, including the energy landscape. We will develop fret-based succinate and citrate sensors to measure the transport activities of individual transporters in single liposomes. These measurements will be used to construct the entire free-energy landscape of the transporter using MD simulations. (4) finally, we will elucidate the mechanisms of inhibition of NACT by several classes of allosteric inhibitors from the pharmaceutical industry to improve their potency and specificity in order to help design better strategies in the treatment of metabolic disorders.

Transactions

Action Obligated Date
Amendment $635,650
Amendment $64,027
Amendment $64,027
Amendment $576,241
Amendment $576,241
Amendment $576,241
Amendment $38,686
Amendment $38,686
Amendment $38,686
Amendment $580,275
Amendment $580,275
Amendment $580,275
Amendment $580,275
Amendment $683,853
Amendment $683,853
Amendment $683,853
Original award $683,853
Show all 17

Subawards

Subrecipient Amount Awarded
The Trustees Of Columbia University In The City Of New York The sodium-dependent citrate transporter (NaCT) plays a major role in fatty acid biosynthesis and as such is a therapeutic target for various metabolic… $212,271
University Of Illinois The sodium-dependent citrate transporter (NaCT) plays a major role in fatty acid biosynthesis and as such is a therapeutic target for various metabolic… $179,410
The Trustees Of Columbia University In The City Of New York $188,072
University Of Illinois $182,614
The Trustees Of Columbia University In The City Of New York This project has 3 major goals: In goal 1, using single nucleus RNA sequencing, we will test how early-life adversity affects the expression profile of distinct… $192,954

Quick answers

Who received award R01DK135088?

R01DK135088 was awarded to New York University by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on January 22, 2023.

How much is award R01DK135088 worth?

$7,664,997 has been obligated on R01DK135088.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login